- Oops!Something went wrong.Please try again later.
Kahn Center for Cardiac Longevity CIMT tests show positive results in arterial age reversal and cardiovascular benefts with BergametNA Citrus Bergamot SuperFruit™
LAS VEGAS, April 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthy Extracts Inc. (OTCQB: HYEX) (the “Company”), a leading developer and manufacturer of science-forward, clinically proven, plant-based and proprietary products for heart and brain health through its subsidiaries, BergametNA™ and Ultimate Brain Nutrients™, is excited to announce that Dr. Joel Kahn, M.D., a world-renowned, triple board-certified cardiology specialist, has joined Healthy Extracts Inc. Dr. Kahn has utilized BergametNA Citrus Bergamot SuperFruit™ with thousands of patients and has seen positive arterial age reversal, arterial flexibility and cardiovascular benefits.
“We are so excited to welcome Dr. Joel Kahn, one of the few triple-certified cardiologists in the entire U.S., to our Medical Board,” stated Duke Pitts, director, president and CEO of Healthy Extracts Inc. “Dr. Kahn’s agreement to join our medical board, based on CIMT results of our heart health products, is truly an exciting development. His addition rounds out our incredibly talented and specialized group of doctors and athletes who are committed to the company’s ‘Live Life Young Again’ philosophy. Dr. Kahn will be instrumental in expanding our doctor-to-doctor and consumer sales.” Anyone interested in improving their heart health should watch this informative video.
“My cardiology career spans over 30 years,” states Dr. Kahn. “I have studied natural health, integrative cardiology and wellness cardiology for over a decade, and I am extremely excited to be involved with the Healthy Extracts Inc. medical board. After all of the research that I have personally conducted and the recent clinical studies that I have confirmed, Citrus Bergamot SuperFruit™, the main ingredient in BergametNA’s proprietary formulations, is the super fruit alternative to prescribed cholesterol management medications in many instances. I believe it is imperative that physicians across North America be made aware of the virtues of BergametNA’s product line and how it can help doctors help their patients naturally.”
About Healthy Extracts Inc.
“Live Life Young Again”
Healthy Extracts Inc. (OCTQB: HYEX) serves as a platform for developing and acquiring complementary companies that feature science-forward, clinically proven, plant-based and proprietary products in select high-margin and high-growth categories within the multibillion-dollar nutraceuticals market – the first two multimillion-dollar examples of which have already been launched.
Company subsidiaries BergametNA™ and Ultimate Brain Nutrients™ (UBN) are providers of nutraceutical natural heart and brain health supplements, including the only heart health supplement containing Citrus Bergamot SuperFruit™, the highest quality and concentration of polyphenols and flavonoids available anywhere in the world and exclusive to BergametNA in North America and backed by 17 clinical studies. UBN’s KETONOMICS® proprietary formulations improve brain health, including memory, cognition, focus and neuro-energy, and have multiple intellectual property license opportunities for monetizing the company’s portfolio. UBN has six unique formulation patents – two issued and four pending.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on April 1, 2020, and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.